Reduced in-hospital survival rates of out-of-hospital cardiac arrest victims with obstructive pulmonary disease  by Blom, M.T. et al.
CR
w
M
A
a
b
c
d
e
a
A
R
R
2
A
K
O
R
S
O
1
c
a
a
t
a
v
a
p
i
0
hResuscitation 84 (2013) 569– 574
Contents lists available at SciVerse ScienceDirect
Resuscitation
jo u rn al hom epage : www.elsev ier .com/ locate / resusc i ta t ion
linical  paper
educed  in-hospital  survival  rates  of  out-of-hospital  cardiac  arrest  victims
ith  obstructive  pulmonary  disease
.T.  Bloma,f,  M.J.  Warnierb,c,f, A.  Bardaia,d,  J.  Berdowskia, R.W.  Kostera,  P.C.  Souvereinc,
.W.  Hoesb,  F.H.  Ruttenb, A.  de  Boerc,  M.L.  De  Bruinb,c,e, H.L.  Tana,∗
Department of Cardiology, Academic Medical Center, University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands
Interuniversity Cardiology Institute Netherlands, Utrecht, The Netherlands
Medicines Evaluation Board (CBG-MEB), P.O. Box 8275, 3503 RG, Utrecht, The Netherlands
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 27 July 2012
eceived in revised form
1 September 2012
ccepted 13 October 2012
eywords:
ut-of-hospital cardiac arrest
esuscitation
urvival
bstructive pulmonary disease
a  b  s  t  r  a  c  t
Aim:  Out-of-hospital  cardiac  arrest  (OHCA)  due  to sustained  ventricular  tachycardia/ﬁbrillation  (VT/VF)
is common  and  often  lethal.  Patient’s  co-morbidities  may  determine  survival  after  OHCA,  and  be  instru-
mental  in  post-resuscitation  care,  but  are  poorly  studied.  We  aimed  to  study  whether  patients  with
obstructive  pulmonary  disease  (OPD)  have  a  lower  survival  rate  after  OHCA  than  non-OPD  patients.
Methods:  We  performed  a community-based  cohort  study  of  1172  patients  with  non-traumatic  OHCA
with  ECG-documented  VT/VF  between  2005  and  2008.  We  compared  survival  to Emergency  Room  (ER),
to  hospital  admission,  to  hospital  discharge,  and  at 30 days  after  OHCA,  of  OPD-patients  and  non-OPD
patients,  using  logistic  regression  analysis.  We  also  compared  30-day  survival  of  patients  who  were
admitted  to hospital,  using  multivariate  logistic  regression  analysis.
Results:  OPD  patients  (n = 178)  and  non-OPD  patients  (n = 994)  had  comparable  survival  to  ER  (75%  vs.
78%,  OR  0.9  [95%  CI: 0.6–1.3])  and  to hospital  admission  (56%  vs.  57%,  OR  1.0  [0.7–1.4]).  However,  sur-
vival  to hospital  discharge  was  signiﬁcantly  lower  among  OPD  patients  (21%  vs.  33%,  OR  0.6 [0.4–0.9]).
Multivariate  regression  analysis  among  patients  who  were  admitted  to hospital  (OPD:  n = 100,  no  OPD:
n = 561)  revealed  that OPD  was  an  independent  determinant  of  reduced  30-day  survival  rate  (39% vs. 59%,
adjusted  OR  0.6  [0.4–1.0,  p = 0.035]).
Conclusion:  OPD-patients  had  lower  survival  rates  after  OHCA  than  non-OPD  patients.  Survival  to  ER
and to  hospital  admission  was  not  different  between  both  groups.  However,  among  OHCA  victims  who
issionsurvived  to hospital  adm
. Introduction
Out-of-hospital cardiac arrest (OHCA) due to ventricular tachy-
ardia/ﬁbrillation (VT/VF) is common and often lethal in both
fﬂuent and developing countries.1,2 Despite much effort, survival
fter OHCA remains poor, even when cardiopulmonary resusci-
ation (CPR) by emergency medical services (EMS) personnel is
ttempted. Survival rate to hospital discharge is generally low and
aries greatly, ranging from 3 to 40%.3,4 This variability is largely
ttributable to differences in the chain of survival: location of OHCA,
resence of a witness, use of automated external deﬁbrillator (AED),
 A Spanish translated version of the summary of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2012.10.009.
∗ Corresponding author. Tel.: +31 20 566 3264; fax: +31 20 697 5458.
E-mail address: h.l.tan@amc.nl (H.L. Tan).
f These authors contributed equally.
300-9572 © 2012 Elsevier Ireland Ltd. 
ttp://dx.doi.org/10.1016/j.resuscitation.2012.10.009
Open access under the Elsevier OA license. ,  OPD  was  an independent  determinant  of  reduced  30-day  survival  rate.
© 2012 Elsevier Ireland Ltd. 
and time of onset of CPR, deﬁbrillation, and advanced care.5–7
However, these factors do not entirely explain the variability in
survival after OHCA. Rea et al. showed that these links in the pre-
hospital chain of care (termed the Utstein measures) collectively
predicted 72% of survival variability among all OHCAs, and 40%
among bystander-witnessed OHCA with VF.6 This indicates that
patient characteristics may  also play an important role. Clearly,
recognizing the role of these characteristics can have important
implications for therapy strategies for OHCA. Yet, reports on the
effects of patient characteristics are scarce (on comorbidities8,9)
and contradicting (on age10,11 and sex12,13).
It is conceivable that obstructive pulmonary disease (OPD; i.e.,
asthma and/or chronic obstructive pulmonary disease [COPD])
may  affect survival rate from OHCA. Adverse effects of ventila-
Open access under the Elsevier OA license. tion and endotracheal intubation during the resuscitation efforts,
and increased hypoxaemia in OPD patients may  negatively impact
the patient’s chance on survival. Also, concomitant (yet often
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nrecognised) cardiac disease in OPD patients may  play a role.14
et, systematic studies on the relation between OPD and survival
ates from OHCA are lacking. The primary aim of our study was
o assess whether OPD patients have a lower survival rate after
HCA than non-OPD patients. We  studied in detail at which point
n the course of post-resuscitation care survival rates between both
roups diverge by comparing survival to emergency room (ER),
urvival to hospital admission, survival to hospital discharge, and
0-day survival. Secondly, we aimed to compare the duration of
ospital care and the quality of outcome (neurologic outcome)
etween OPD patients and non-OPD patients who were discharged
rom hospital alive.
. Methods
.1. Setting and study region
The AmsteRdam REsuscitation STudy (ARREST) research group
rospectively collects data of all OHCA since June 2005 in the North
olland province of the Netherlands. This region covers 2404 km2
urban and rural communities) and had a population of 2 426 097
n 2007.15 In case of a medical emergency, people dial the national
mergency number. Calls are transferred to the regional EMS  dis-
atch centre. When suspecting a cardiac arrest, the EMS  dispatcher
ends out 2 ambulances from a single tier.16 Further details of the
MS system were described elsewhere.17
.2. Study design
Data of all resuscitations during the study period, from arrival
f EMS  personnel until hospital discharge or death, were collected
ccording to Utstein recommendations.18 To determine the sur-
ival of OHCA victims with or without OPD, a prospective cohort
tudy was performed. This study was conducted according to
he principles expressed in the Declaration of Helsinki. Written
nformed consent was obtained from all participants who  sur-
ived OHCA. The Ethics Committee of the Academic Medical Center
msterdam approved the study, including the use of data from
atients who did not survive OHCA.
.3. Patient selection
Of each patient in whom a resuscitation attempt was  under-
aken by EMS personnel, the ECG from the ambulance or AED
as retrieved and analysed. Patients were included for the present
tudy if they had OHCA with ECG-documented VT/VF from pre-
umed cardiac causes. All OHCAs were considered to be from
ardiac causes unless an unequivocal non-cardiac cause was  docu-
ented (i.e., drowning or trauma). This was veriﬁed by reviewing
ll case ﬁles. We  excluded EMS-witnessed OHCAs, since emer-
ency call – response intervals and immediate resuscitation by
MS personnel have enormous impact on survival chances,6 and
xcluded aborted resuscitation efforts in individuals with a “do
ot resuscitate” status. As we aimed to perform a complete
ase analysis, we excluded patients of whom the medication
istory of the year before OHCA could not be retrieved, and
hose of whom data on the chain of resuscitation care were
issing.
.4. Deﬁnitions and covariatesOHCA was deﬁned as the cessation of cardiac mechanical activ-
ty as conﬁrmed by the absence of signs of circulation,18 occurring
ut-of-hospital. Patients were considered to have OPD if they
ad at least two prescriptions of any medication with Anatomicaln 84 (2013) 569– 574
Therapeutic Chemical classiﬁcation system (ATC) code R03 (drugs
for obstructive airway diseases) in the year before OHCA. Data
of medication use at the time of OHCA, and in the year
before OHCA, were obtained from the patient’s community phar-
macy.
Survival was  assessed at different time points: survival to
emergency room (ER), survival to hospital admission, survival to
hospital discharge (information retrieved from hospital records),
and 30-day survival (retrieved from the civic registry). Duration
of hospital care (in days) was retrieved from hospital records.
Two researchers (JB and AB) classiﬁed neurologic outcome on
the Cerebral Performance Category (CPC) scale by reviewing hos-
pital charts of patients who survived until hospital discharge.
Category 1 represents good cerebral performance; category 2, mod-
erate cerebral disability; category 3, severe cerebral disability;
category 4, coma or vegetative state; and category 5, death.19
Neurologically intact survival was deﬁned as CPC category 1 or
2.18
The following prognostic factors were considered to be poten-
tial confounding factors: older age (>65 years), sex, cardiovascular
co-morbidity (deﬁned by medication use: -adrenoceptor block-
ers, calcium antagonists, angiotensin converting enzyme inhibitors,
diuretics, angiotensin-II receptor blockers, platelet aggregation
inhibitors, nitrates and/or statins within 6 months before OHCA),
bystander witnessed OHCA, public location of OHCA, bystander CPR
performed, use of AED, and time interval from emergency call to
arrival of EMS  personnel.
2.5. Data analysis
To establish the association between OPD and survival after
OHCA, we ﬁrst studied all OHCA patients with documented VT/VF
(n = 1172, Fig. 1). As primary outcome measure in this analysis, we
used 30-day survival, as this can be determined for all patients
regardless of hospitalisation status. Secondary outcome measures
were survival rates at succeeding stages in the chain of care:
(i) survival to arrival at the ER, (ii) survival to hospital admis-
sion and (iii) survival to hospital discharge. We  performed logistic
regression analysis for survival at all stages, adjusting for age and
sex.
Next, we determined at which stage of the chain of care survival
diverged between OPD patients and non-OPD patients. We  then
selected all patients who  survived up to that stage, and performed
multivariate logistic regression analysis, using 30-day survival as
outcome measure. We applied two  multivariate models: (1) with
adjustment for all covariates that were univariately associated with
OHCA with VT/VF, and (2) with adjustment for all covariates that
were univariately associated with OHCA with VT/VF and changed
the point estimate of the association between OPD and outcome
with at least 5%.20 Interaction between OPD and either older age,
sex or concomitant cardiovascular disease was estimated by includ-
ing the cross product of the two factors as a variable in the model.
Results are presented as odds ratio (OR) and 95% conﬁdence inter-
vals (95% CI).
To compare duration of hospital care and quality of outcome
between OPD patients and non-OPD patients who were discharged
from the hospital alive, we  studied duration of hospital care (in
days) and neurologic status at hospital discharge of the patients
who were discharged from the hospital alive.
Continuous variables were described as means and standard
deviations (SD), or medians and interquartile range where
appropriate, and categorical variables as absolute numbers and
percentages. Comparisons between groups were performed with
chi-square test or analysis of variance were appropriate. All data
were analysed using the statistical software package of SPSS (SPSS
for Mac, version 18.0, SPSS Inc.).
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. Results
During the 43-month study period, there were 5812 emergency
alls with EMS dispatchers suspecting OHCA. In 3821 instances,
MS  personnel attempted to resuscitate. There were 3290 patients
ith OHCA from presumed cardiac causes, including 1970 with
ocumented VT/VF. After exclusion of non-eligible patients (in 605
atient data unavailable, in 139 EMS-witnessed OHCA, in 54 data onatient inclusion.
circumstances of OHCA unavailable), the analysis cohort consisted
of 1172 patients (Fig. 1). Age and sex of included and excluded
patients were not meaningfully different: age 63.5 (14.5) vs. 65.8
(14.3) years, respectively, p < 0.001; male sex 78% in both groups,
p = 0.78.
Baseline characteristics of OHCA patients with OPD (n = 178) and
without OPD (n = 994) are shown in Table 1. OPD patients were
older (70 [12] vs. 65 [15] years, p < 0.001), less often male (71 vs.
572 M.T. Blom et al. / Resuscitation 84 (2013) 569– 574
Table  1
Baseline characteristics of the study population (all patients: n = 1172, patients admitted to hospital alive: n = 661).
Baseline characteristics All patients Patients admitted to hospital alive
OPD No OPD p-Value OPD No OPD p-value
Events, n 178 994 100 561
Mean  age (years, SD) 70 (12) 65 (15) < 0.001 69 (12) 64 (14) 0.006
Older age (≥65 years), n (%) 123 (69%) 545 (55%) < 0.001 67 (67%) 295 (53%) 0.008
Male  sex 127 (71%) 785 (79%) 0.024 66 (66%) 439 (78%) 0.008
Cardiovascular disease, n (%)a 142 (80%) 668 (67%) 0.001 79 (79%) 387 (69%) 0.043
Resuscitation parameters:
Collapse at public location, n (%) 50 (28%) 385 (39%) 0.007 34 (34%) 249 (44%) 0.053
Witnessed collapse, n (%) 152 (85%) 855 (86%) 0.826 86 (86%) 512 (91%) 0.099
Bystander CPR performed, n (%) 122 (69%) 734 (74%) 0.142 68 (68%) 436 (78%) 0.035
AED  used, n (%) 31 (17%) 258 (26%) 0.015 21 (21%) 168 (30%) 0.068
EMS  response time, median (Q1–Q3) (min) 10.4 (8.0–13.1) 9.6 (7.5–11.9) 0.021 9.9 (7.4–13.1) 9.0 (6.8–11.5) 0.075
AED: automated external deﬁbrillator; CPR: cardiopulmonary resuscitation; EMS: emergency medical services; OPD: obstructive pulmonary disease; Q: quartile; SD: standard
deviation. Comparisons of continuous variables were made with ANOVA; the 2 test was  used when binary variables were compared. All statistical tests were 2 tailed.
a Use of -adrenoceptor blocker, calcium antagonist, angiotensin converting enzyme inhibitor, diuretic, angiotensin-II receptor blocker, platelet aggregation inhibitors,
nitrate and/or statin within 6 months prior to out-of-hospital cardiac arrest.
Table 2
Survival rates and Odds Ratio for survival at various stages, patients with and without OPD (n = 1172).
Outcome Patients with OPDn = 178 Patients without OPDn = 993 ORa (95% CI)
30-day survival, n (%) 40 (23) 333 (34) 0.7 (0.5–0.97)
Survival to ER, n (%) 134 (75) 779 (78) 0.9 (0.6–1.3)
Survival to hospital admission, n (%) 100 (56) 561 (57) 1.0 (0.7–1.4)
Survival to hospital discharge, n (%) 38 (21) 329 (33) 0.6 (0.4–0.9)
C  OR: o
7
m
l
l
l
O
w
O
a
a
F
gI: conﬁdence interval; ER: emergency room; OPD: obstructive pulmonary disease;
a ORs are corrected for age and sex.
9%, p = 0.02), and more often used (any type of) cardiovascular
edication (80 vs. 67%, p = 0.001). In OPD patients, OHCA occurred
ess often at a public location (28 vs. 39%, p = 0.007), AED use was
ess common (17 vs. 26%, p = 0.02), and EMS  response time was
onger (10.4 vs. 9.6 min, p = 0.02). Survival rates of OPD and non-
PD patients are shown in Fig. 2 and Table 2. Thirty-day survival
as lower in OPD patients than in non-OPD patients (23 vs. 34%,
R 0.7 [0.5–0.97]). However, survival to ER was comparable (75
nd 78%, respectively, OR 0.9 [0.6–1.3]), as was survival to hospital
dmission (56 and 57%, OR 1.0 [0.7–1.4]). In contrast, survival to
ig. 2. Survival rates after OHCA of OPD patients and non-OPD patients, at emer-
ency room, hospital admission and hospital discharge.dds ratio.
hospital discharge was lower in OPD patients (21 vs. 33%, OR 0.6
[0.4–0.9]).
Since survival rates of OPD patients became lower than those
of non-OPD patients only after admission to the hospital, we stud-
ied the cohort of patients who were admitted to the hospital alive
(n = 661, Fig. 1, Table 1) to establish whether OPD was an inde-
pendent determinant of lower survival rate. Within this cohort,
OPD patients were older than non-OPD patients (69 (12) vs. 65
(14) years, p = 0.006), less often male (66 vs. 78%, p = 0.008), and
more often received (any) cardiovascular medication (79 vs. 69%,
p = 0.043). While all resuscitation parameters were less favourable
for OPD patients, only the lower rate of bystander CPR reached sta-
tistical signiﬁcance. Table 3 shows ORs for 30-day survival in this
cohort, calculated with univariate and multivariate regression anal-
ysis (two models). OPD patients had a lower chance of survival (39%
vs. 59%, p < 0.001; adjusted OR [ﬁrst model] 0.6 [0.4–0.99], p = 0.047,
adjusted OR [second model] 0.6 [0.4–0.95], p = 0.035). No signiﬁcant
interaction between age, sex or concomitant cardiovascular disease
and OPD was observed.
Among patients who were discharged from hospital alive, dura-
tion of hospital care was not different between OPD patients and
non-OPD patients (26 vs. 27 days, p = 0.825, Table 4). Also, CPC
scores were similar (Table 4), as was  the proportion of neurologi-
cally intact survival (95% and 94%, p = 0.787).
4. Discussion
Patients with OPD had a 40% lower chance on 30-day survival
after OHCA than patients without OPD. Survival rates were similar
for OPD patients and non-OPD patients at the ﬁrst stages of resus-
citation care (survival to ER and survival to hospital admission);
it is only after admission to hospital that the survival rate of OPD
patients became lower than of non-OPD patients. These ﬁndings
support the idea that survival at early stages is mostly determined
by pre-hospital chain of care factors, while patient characteristics
play a larger role in late (eventual) survival.
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Table 3
Thirty-day survival for patients with or without OPD who were admitted to the hospital alive (n = 661).
30-day survival Crude OR (95%CI) Adjusted ORa
(95%CI)
Adjusted ORb
(95%CI)
Yes (n = 371) No (n = 290)
OPD, n (%) 39 (11) 61 (21) 0.4 (0.3–0.7) 0.6 (0.4–0.99) 0.6 (0.4–0.95)
Age,  mean ± SD 62 ± 14 70 ± 13 0.95 (0.94–0.97) 0.96 (0.94–0.97) 0.96 (0.95–0.97)c
Male sex, n (%) 302 (81) 203 (70) 1.9 (1.3–2.7) 1.7 (1.1–2.5) 1.6 (1.1–2.4)d
Cardiovascular disease,e n (%) 236 (64) 230 (79) 0.5 (0.3–0.7) 0.8 (0.5–1.2) 0.8 (0.5–1.2)
OHCA  at public location, n (%) 191 (52) 92 (32) 2.3 (1.7–3.1) 1.7 (1.2–2.4) 1.7 (1.2–2.4)
Witnessed OHCA, n (%) 353 (95) 245 (85) 3.6 (2.0–6.4) 3.1 (1.7–5.8)
Bystander CPR performed, n (%) 305 (82) 199 (69) 2.1 (1.5–3.0) 1.2 (0.8–1.9) 1.5 (1.0–2.2)
AED  used, n (%) 131 (35) 58 (20) 2.2 (1.5–3.1) 1.7 (1.1–2.5)
EMS  response time in min, median (Q1–Q3) 8.4 (6.0–10.7) 10.0 (8.0–12.7) 0.93 (0.90–0.97) 0.95 (0.91–0.99) 0.94 (0.90–0.98)
AED: automated external deﬁbrillator; CI: conﬁdence interval; CPR: cardiopulmonary resuscitation; EMS: emergency medical services; min: minutes; n: number; OHCA:
out-of-hospital cardiac arrest; OPD: obstructive pulmonary disease; OR: odds ratio; SD: standard deviation.
a Adjusted for all covariates that were univariately associated with outcome.
b Adjusted for all covariates that were univariately associated with outcome and that changed the beta with at least 5% (age, sex, cardiovascular medication, collapse at
public  location, bystander CPR performed, EMS  response time).
c Interaction OPD and older age on a multiplicative scale: OR 0.9 (95% CI 0.3–2.4), p = 0.832.
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Cd Interaction OPD and sex on a multiplicative scale: OR 1.0 (95% CI 0.4–2.7), p = 0.
e Use of -adrenoceptor-blocker, calcium antagonist, angiotensin converting en
itrate  and/or statin within 6 months prior to out-of-hospital cardiac arrest.
In accordance with our ﬁndings, Carew et al.8 reported that
he chance of survival after OHCA declines as the number of
o-morbidities (including lung disease) increases. However, co-
orbidities in the study of Carew were not so well ascertained as
n our study because they were collected solely from EMS  reports.
oreover, their analysis included ambulance witnessed arrests,
hich arguably could be considered as in-hospital cardiac arrests
hen analysing survival. Most importantly, we discovered that
eduction in survival rate of OPD patients (relative to non-OPD
atients) occurs when these patients are already admitted to hos-
ital. This ﬁnding indicates that it should be feasible to modify
reatment strategies in such a way that this mortality gap can be
losed (treatment strategies for pre-hospital or in-community care
ould be much more difﬁcult to implement). Such efforts should
e targeted at the pathophysiologic mechanisms that underlie the
ower survival rates in OPD patients. While we did not study these
echanisms, various explanations may  be proposed. Firstly, OPD
atients have a lower potential for oxygen uptake, and may  there-
ore have lower ‘oxygen reserve’, and be more vulnerable to the
eleterious effects of hypoxaemia during cardiac arrest and resus-
itation. Also, endotracheal intubation and ventilation during the
esuscitation efforts might enhance the inﬂammatory response in
heir already affected airways. Both mechanisms may adversely
nﬂuence survival. Clearly, future studies must address these issues.
Still, improved pre-hospital or in-community treatments to
educe risk of OHCA or survival from OHCA in OPD patients
ust also be considered. For instance, at present, -adrenoceptor
lockers are the only drugs that have shown to prevent sudden
ardiac death in some patient categories, notably cardiomyopa-
hy, heart failure, coronary artery disease, and hemodialysis.21–23
raditionally, -adrenoceptor blockers have been considered
ontra-indicated in COPD patients, although evidence indicates
able 4
eurologic outcome and duration of hospital admission for patients with and without OP
OPD
(n = 38)
CPC-score 
Good  cerebral performance (CPC = 1), n (%) 31 (82) 
Moderate cerebral disability (CPC = 2), n (%) 5 (13) 
Severe cerebral disability (CPC = 3), n (%) 1 (3) 
Coma or vegetative state (CPC = 4), n (%) 1 (3) 
Duration of hospital admission, days (SD) 26 (17) 
PC: cerebral performance category; OPD: obstructive pulmonary disease; SD: standard dinhibitor, diuretic, angiotensin-II receptor blocker, platelet aggregation inhibitors,
that at least cardio-selective -adrenoceptor blockers are well
tolerated by COPD patients.24 Interestingly, recent observational
studies suggest that long-term treatment with -adrenoceptor
blockers may  improve survival of COPD patients, including those
without known cardiovascular disease.25,26 As COPD patients have
a worse prognosis after OHCA, future research must establish
whether or not -adrenoceptor blockers should be given to COPD
patients with an indication for these drugs.
A major strength of our study is that ARREST was  speciﬁcally
designed to study the determinants and outcomes of OHCA. This
ensured that OHCA diagnosis was  accurate. A cardiac cause of OHCA
was validated by the presence of VT/VF on the ECG. This is especially
important in patients with OPD, because sudden death caused by
cardiac arrest may  easily be confused with sudden death caused
by respiratory failure.14 Another strength is that our ﬁndings are
representative for the community at large, because we studied the
general population, including both urban and rural areas, and cap-
tured ∼90% of all OHCA cases.27
Some limitations of our study should also be discussed. Non-
differential misclassiﬁcation in the diagnosis of OPD  could have
occurred, as we deﬁned the presence of the disease by the use
of two prescriptions of respiratory drugs within 1 year before
OHCA. However, these drugs are indicated exclusively for OPD, and
patients with OPD who received less than two prescriptions of any
respiratory drug most likely are patients with very mild disease;
the misclassiﬁcation therefore would result in underestimation
of the effect. Similarly, our diagnosis of CVD was  based on the
use of -adrenoceptor blockers, calcium antagonists, angiotensin
converting enzyme inhibitors, diuretics, angiotensin-II receptor
blockers, platelet aggregation inhibitors, nitrates and/or statins
within 6 months before OHCA. Other deﬁnitions, e.g. the use of
antidiabetic medication, anti-arrhythmic drugs or digitalis, may
D who were discharged from hospital alive (n = 367).
No OPD
(n = 329)
p-Value
0.507
265 (81)
43 (13)
19 (6)
2 (1)
27 (19) 0.825
eviation.
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ead to different classiﬁcations. Still, it may  be assumed that
atients with a recognised high cardiac risk proﬁle will use at least
ne of the drugs in the categories of our deﬁnition. Furthermore,
ur ﬁndings may  partly be explained by the possibility that some
atients have been misdiagnosed as OPD, due to misinterpreta-
ion of their dyspnoea or other symptoms, while in fact they had
nrecognised heart failure.14 Finally, OPD treatment withdrawal
ubsequent to the resuscitation may  explain part of the observed
ifference in survival, but was not assessed in our study. Future
tudies should establish whether in-hospital post-resuscitation
are includes sufﬁcient attention for OPD treatment.
In conclusion, we found that OPD patients have a 40% lower
hance on 30-day survival after OHCA than non-OPD patients.
urvival rates were similar in both groups at the ﬁrst stages of
esuscitation care (survival to ER and survival to hospital admis-
ion); it is only after admission to hospital that survival rates of
PD patients became lower than those of non-OPD patients. Our
ndings suggest that in-hospital post-resuscitation care of OPD
atients who suffered OHCA should be adapted in order to close
his mortality gap. We  aim to raise awareness of the lower survival
hances of OPD patients after OHCA; closer monitoring of these
atients may  provide insight into the pathophysiologic basis of this
ifference.
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